mci 9038 has been researched along with Brain Hemorrhage in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, HS; Cui, Y; Hou, XW; Li, XQ; Tian, XF; Wang, XH; Zhou, ZH | 1 |
| Brown, PM; Hursting, MJ; LaMonte, MP; Nash, ML; Schultz, J; Wang, DZ; Woolfenden, AR | 1 |
2 trial(s) available for mci 9038 and Brain Hemorrhage
| Article | Year |
|---|---|
Safety and preliminary efficacy of argatroban plus dual antiplatelet therapy for acute mild to moderate ischemic stroke with large artery atherosclerosis.
Topics: Arginine; Arteries; Atherosclerosis; Hemorrhage; Humans; Intracranial Hemorrhages; Ischemic Stroke; Pipecolic Acids; Platelet Aggregation Inhibitors; Prospective Studies; Retrospective Studies; Sulfonamides; Treatment Outcome | 2022 |
Argatroban anticoagulation in patients with acute ischemic stroke (ARGIS-1): a randomized, placebo-controlled safety study.
Topics: Aged; Anticoagulants; Arginine; Double-Blind Method; Drug Administration Schedule; Female; Humans; Intracranial Hemorrhages; Male; Middle Aged; Partial Thromboplastin Time; Pipecolic Acids; Stroke; Sulfonamides; Survival Analysis | 2004 |